system because nerve terminals containing PACAP-like imin concentrations (10-30 nM) that caused no significant change of holding currents, reversibly increased NMDA-induced currents munoreactivity have been shown to make synaptic-like conbut not KA-induced currents. At higher concentrations (ú30 nM), tacts with retrogradely labeled SPNs in the rat intermediolatthe peptide produced a sustained inward current. The potentiating eral cell column (Chiba et al. 1996; Dun et al. 1996b ). superfusing the slices with the membrane-permeable cyclic AMP analogue N 6 ,2-0-dibutyryladenosine 3:5-cyclic monophosphate (100-300 mM) in the presence of the phosphodiesterase inhibitor M E T H O D S 3-isobutyl-1-methylxanthine (700 mM) increased the NMDA currents. This result suggests that PACAP selectively increases Procedures used in obtaining 500-mm transverse thoracolumbar NMDA-receptor-mediated responses in the rat SPNs, probably via spinal cord slices from 12-to 16-day-old Sprague-Dawley rats a cyclic-AMP-dependent mechanism, providing evidence that the have been described (Shen and Dun 1990; Wu and Dun 1996b) . peptide may be involved in synaptic plasticity.
Some of the results have appeared as an abstract (Wu and the adenylate cyclase inhibitor MDL-12,330A (25 mM). Further, .
superfusing the slices with the membrane-permeable cyclic AMP analogue N 6 ,2-0-dibutyryladenosine 3:5-cyclic monophosphate (100-300 mM) in the presence of the phosphodiesterase inhibitor M E T H O D S 3-isobutyl-1-methylxanthine (700 mM) increased the NMDA currents. This result suggests that PACAP selectively increases Procedures used in obtaining 500-mm transverse thoracolumbar NMDA-receptor-mediated responses in the rat SPNs, probably via spinal cord slices from 12-to 16-day-old Sprague-Dawley rats a cyclic-AMP-dependent mechanism, providing evidence that the have been described (Shen and Dun 1990; Wu and Dun 1996b) . peptide may be involved in synaptic plasticity.
Spinal slices were superfused with a Krebs solution of the following composition (in mM): 117 NaCl, 2.0 KCl, 1.2 KH 2 PO 4 , 2. form in mammalian tissues (Arimura 1992) . The amino acid hydroxyethylpiperazine-N-2-ethanesulfonic acid, patch electrodes sequence of PACAP-38 is well preserved in different species had a resistance of 3-5 MV. With the exception of glutamate and is identical in sheep, rat, and human (Arimura 1992 (Shivers et al. 1991) . Type I receptors 6-cyano-7-nitroquinoxaline-2,3-dione (CNQX) were purchased are positively coupled to adenylate cyclase and phospholi-from Tocris Cookson (St. Louis, MO); PACAP-38 was purchased pase C, whereas type II receptors are linked to adenylate from Peninsula Laboratories (Belmont, CA); MDL-12,330A and cyclase only (Spengler et al. 1993 ). Activation of intracellu-tetrodotoxin were purchased from RBI (Natick, MA); and other the holding currents were not significantly changed in any of these neurons. PACAP (10 nM) caused a small (12-SPNs in the intermediolateral cell column of spinal slices 16%) but statistically insignificant increase of NMDA curwere identified by their location and by the appearance of rents (n Å 4, P ú 0.05), whereas PACAP (1 nM) produced an antidromic spike following stimulation of ventral rootlets no detectable increase in NMDA currents (n Å 3). At higher (Shen and Dun 1990). These neurons had a mean resting concentrations (ú30 nM), the peptide produced a sustained potential, input resistance, and time constant of 061 { 7 inward current in SPNs . Because mV, 530 { 68 MV, and 43 { 6 ms (n Å 32), which were PACAP (30 nM) consistently potentiated NMDA currents comparable with those reported earlier (Wu and Dun without causing a significant change of holding currents, 1996b).
this concentration was used in all the experiments described A brief (duration 10-20 ms) puff of NMDA or KA by below. The potentiation lasted 10-20 min and could be pressure to SPNs voltage clamped to 060 mV, which is demonstrated in SPNs irrespective of the presence or absence close to the resting potential of these neurons, evoked an of Mg 2/ ions in the superfusing solution. Figure 1 5.7% (n Å 6) over the respective control responses (Fig.  1) but not the KA currents; the peak NMDA currents were 2); the differences were statistically significant (P õ 0.05). increased by an average of 120 { 10% (n Å 5, P õ 0.05) in PACAP (30 nM) increased the NMDA currents by an averMg 2/ -free solution as compared with control Krebs solution. age of 41 { 4.5% (n Å 4, P õ 0.05) from spinal cord slices treated with tetrodotoxin (0.3 mM). Last, NMDA currents Effects of PACAP on SPNs evoked in SPNs were effectively blocked by AP5 (10-20 PACAP, by superfusion to SPNs in slices, produced two mM) in all four neurons tested (Fig. 1) . PACAP in the concentrations that potentiated NMDA currents had no sigconspicuous effects that were concentration dependent. At pA (n Å 8) and the difference was statistically insignificant (P ú 0.05, Fig. 2 ). KA currents evoked in SPNs were reversibly blocked by CNQX (1 mM), as shown in Fig. 3 .
Involvement of adenylate cyclase
The membrane-permeable cyclic AMP analogue N 6 ,2-0-dibutyryladenosine 3:5-cyclic monophosphate (dbcAMP, 300 mM) in the presence of the phosphodiesterase inhibitor 3-isobutyl-1-methylxanthine (IBMX, 700 mM) potentiated the NMDA currents (Fig. 4) ; the mean increase was 46 { 9.7% (n Å 5, Fig. 2 ). In the concentrations used here, dbcAMP or IBMX alone caused a small but statistically insignificant increase of NMDA currents in four neurons tested (P ú 0.05). Incubation of the spinal cord slices with MDL-12,330A (25 mM), an adenylate cyclase inhibitor (Lippe and Ardizzone 1991), effectively blocked the potentiating effect of PACAP in all five neurons examined (Fig. 2) . A representative experiment is shown in Fig. 4 . Neither the holding current nor the amplitude of NMDA current was significantly changed by MDL-12,330A alone.
D I S C U S S I O N
The peptide PACAP at concentrations of°30 nM selectively enhanced NMDA currents but not KA currents in FIG of Mg 2/ ions. In this respect, protein kinase C appears to potentiate NMDA currents in isolated trigeminal neurons by reducing the Mg 2/ block of NMDA receptor channels (Chen nificant effect on KA currents in any of the eight SPNs tested (Fig. 3) . The mean amplitude of KA currents before and Huang 1992). Moreover, PACAP potentiated NMDA currents in a tetrodotoxin-containing medium, indicating that and after PACAP (30 nM) was 83 { 49 pA and 80 { 47   FIG . 3 . Lack of potentiation of KA currents by PACAP in an SPN. KA applied by pressure (1 mM, ᭢ ) evoked inward current, which was not enhanced by superfusing slice with PACAP (30 nM; between F and f). 6-Cyano-7-nitroquinoxaline-2,3-dione (CNQX, 1 mM, horizontal bar) reversibly blocked KA currents. Chart recordings were interrupted by 3 periods of 3, 6, and 3 min. FIG . 4. Potentiation of NMDA currents by dbcAMP and by PACAP in neonatal rat SPNs. A: NMDA currents induced by pressure application of NMDA (1 mM, pulse duration 10 ms, marked by arrowhead) were increased by addition of dbcAMP (300 mM) and the phosphodiesterase inhibitor IBMX (700 mM), as indicated by the 2 arrows. This effect was reversible after period of wash with normal Krebs solution. Continuous chart recording was interrupted by 2 periods lasting 8 and 4 min. B: NMDA currents in this neuron were first increased by superfusing slice with PACAP (30 nM), applied between the 2 arrowheads. After NMDA responses had returned to control level, the adenylate cyclase inhibitor MDL-12,330A (25 mM) was added to Krebs solution. Addition of PACAP, as indicated by horizontal bar, caused no increase of NMDA currents in presence of MDL-12,330A. Both neurons were voltage clamped to 060 mV. the potentiation is not likely to be caused secondarily by a a cAMP-dependent protein kinase mechanism in basolateral amygdala and cultured hippocampal neurons (Huang et al. release of bioactive substances from the spinal cord slices.
The possibility that adenylate cyclase may be the intracel-1993; Raman et al. 1996) , whereas activation of protein kinase C appears to be involved in the sustained potentiation lular messenger underlying the PACAP-mediated potentiation is suggested by the following observations. First, incu-of NMDA responses by the m-opioid receptor agonist DAla 2 -MePhe 4 -gly-ol 5 -enkephalin (Chen and Huang 1991) bation of the spinal cord slices with the adenylate cyclase inhibitor MDL-12,3330A effectively prevented the potenti-and by the tachykinins substance P and neurokinin A . In addition to neuropeptides, activation of meating effect of a second application of PACAP in SPNs in which an enhancement of NMDA currents could first be tabotropic receptors has been shown to selectively potentiate NMDA but not a-amino-3-hydroxy-5-methyl-4-isoxazoledemonstrated by the peptide. Second, the membrane-permeable dbcAMP in the presence of a phosphodiesterase inhibi-propionic acid responses in hippocampal neurons (Aniksztejn et al. 1991; Harvey and Collingridge 1993) . The mechator mimicked the potentiating effect of PACAP. A potentiation of NMDA currents via a cyclic-AMP-dependent mecha-nism underlying metabotropic-receptor-agonist-mediated potentiation of NMDA responses appears also to be cyclic nism has been reported by several groups of investigators. For example, NMDA currents were enhanced by 8-bromo-AMP independent (Harvey and Collingridge 1993) .
PACAP is homologous to a peptide that is thought to be cyclic AMP, or by intracellular application of adenosine 3,5-cyclic monophosphate (cAMP) or of catalytic subunits involved in memory storage in Drosophila (Feaney and Quinn 1995) . Glutamate-receptor-mediated long-term poof protein kinase A (Cerne et al. 1993) . Similarly, activation of b-adrenergic receptors potentiated NMDA responses via tentiation is implicated in certain forms of synaptic plasticity cyclase activating peptide immunoreactivity in the rat spinal cord and in the mammalian central synapse (Greengard et al. 1991;  brainstem: implication of sensory and autonomic functions. Neuroscience Siegelbaum and Kandel 1991 ) is similar to that of the rat campal neurons. Science 253: 1136-1138, 1991. and mouse spinal cord (Dun et al. 1996b; Narita et al. 1996) , HARVEY, J. AND COLLINGRIDGE, G. L. Signal transduction pathway involved underscoring the potential importance of this peptide in synin the acute potentiation of NMDA responses by 1S,3R-ACPD in rat hippocampal slices. Br. J. Pharmacol. 109: 1085 Pharmacol. 109: -1090 Pharmacol. 109: , 1993 aptic plasticity of all mammals. Furthermore, our results HUANG, C. C., TSAI, J. J., AND GEAN, P. W. Enhancement of NMDA recepsupport the concept that a common pathway may exist betor-mediated synaptic potential by isoproterenol is blocked by R p -adenotween neuropeptides and adenylate cyclase cascade on one sine 3,5-cyclic monophosphothioate. Neurosci.  hand and synaptic plasticity on the other (Kandel and Abel 1993.
